Altered fractionated radiotherapy in the management of head and neck carcinomas: advantages and limitations
- 1 May 2004
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Oncology
- Vol. 16 (3) , 215-219
- https://doi.org/10.1097/00001622-200405000-00004
Abstract
This article provides an overview of randomized studies of altered fractionated radiotherapy (RT) in Head and Neck squamous cell carcinoma. Both hyperfractionated RT and accelerated RT may improve tumor control probability as compared to conventional RT, along with increased but manageable toxicity and a modest improvement in survival. Altered RT is a tool that can improve the results obtained with conventional RT in Head and squamous cell carcinoma.Keywords
This publication has 21 references indexed in Scilit:
- Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal CancerNew England Journal of Medicine, 2003
- Altered fractionation and combined radio-chemotherapy approachesEuropean Journal Of Cancer, 2003
- Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systemsInternational Journal of Radiation Oncology*Biology*Physics, 2003
- A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003Published by Elsevier ,2000
- Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual dataThe Lancet, 2000
- Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trialRadiotherapy and Oncology, 1997
- A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancerRadiotherapy and Oncology, 1997
- Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapyRadiotherapy and Oncology, 1992
- Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Twice a day versus once a day radiation therapy in head and neck cancerInternational Journal of Radiation Oncology*Biology*Physics, 1989